These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16523070)

  • 1. Administering immune globulin.
    Rosenthal K
    Nursing; 2006 Mar; 36(3):20-1. PubMed ID: 16523070
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of immune globulin intravenous and thromboembolic adverse events.
    Ovanesov MV; Menis MD; Scott DE; Forshee R; Anderson S; Bryan W; Golding B
    Am J Hematol; 2017 Apr; 92(4):E44-E45. PubMed ID: 28066925
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicity of rapidly infused concentrated intravenous immune globulin.
    Ippoliti C; Williams LA; Huber S
    Clin Pharm; 1992 Dec; 11(12):1022-6. PubMed ID: 1286551
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immune globulin in neuromuscular disorders.
    Gupta S
    West J Med; 1997 Nov; 167(5):349-50. PubMed ID: 9392991
    [No Abstract]   [Full Text] [Related]  

  • 5. Nursing guidelines for administration of immunoglobulin replacement therapy.
    Younger ME; Aro L; Blouin W; Duff C; Epland KB; Murphy E; Sedlak D;
    J Infus Nurs; 2013; 36(1):58-68. PubMed ID: 23271153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous immune globulin for stiff-person syndrome.
    Sudo K; Tajima Y; Matsumoto A
    N Engl J Med; 2002 May; 346(22):1747-8; author reply 1747-8. PubMed ID: 12037158
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose intravenous immune globulin for stiff-person syndrome.
    Solaro C
    N Engl J Med; 2002 May; 346(22):1747-8; author reply 1747-8. PubMed ID: 12041528
    [No Abstract]   [Full Text] [Related]  

  • 8. [High dose intravenous immunoglobulins in therapeutic arsenal in autoimmune and systemic diseases].
    Klein M; Kaminsky P; Duc M
    Therapie; 1993; 48(2):97-103. PubMed ID: 8351694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important drug warning: Immune Globulin Intravenous (human) (IGIV) products.
    Epstein JS; Zoon KC
    Neonatal Netw; 2000 Mar; 19(2):60-2. PubMed ID: 11949001
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and tolerability of an intravenous immune globulin at various concentrations in 5% dextrose injection or sterile water for injection.
    Miller KB; Schenkein DP; Wasserman RL
    Clin Pharm; 1992 Jul; 11(7):628-31. PubMed ID: 1617914
    [No Abstract]   [Full Text] [Related]  

  • 11. Side-effects of intravenous immune globulins.
    Duhem C; Dicato MA; Ries F
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home infusion of intravenous immune globulin in human immunodeficiency virus--infected children.
    Poole JK
    J Intraven Nurs; 1993; 16(3):195. PubMed ID: 8515340
    [No Abstract]   [Full Text] [Related]  

  • 13. Is pertussis immune globulin efficacious for the treatment of hospitalized infants with pertussis? No answer yet.
    Halperin SA; Vaudry W; Boucher FD; Mackintosh K; Waggener TB; Smith B;
    Pediatr Infect Dis J; 2007 Jan; 26(1):79-81. PubMed ID: 17195712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of intravenous immunoglobulins.
    Martin TD
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():514-20. PubMed ID: 10689502
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders.
    Grillo JA; Gorson KC; Ropper AH; Lewis J; Weinstein R
    Neurology; 2001 Nov; 57(9):1699-701. PubMed ID: 11706114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulins.
    Webster AD
    BMJ; 1991 Aug; 303(6799):375-6. PubMed ID: 1912799
    [No Abstract]   [Full Text] [Related]  

  • 17. [Known and potential risks related to the use of high dose intravenous immunoglobulins].
    Bussel A
    Ann Dermatol Venereol; 1997; 124(5):381-3. PubMed ID: 9739894
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura.
    Ruggeri M; Castaman G; De Nardi G; Rodeghiero F
    Haematologica; 1993; 78(5):338-9. PubMed ID: 8314166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome?
    Federici AB; Rossi V; Sacchi E; Franchini M
    Blood Transfus; 2012 Jul; 10(3):402-3; author reply 404-5. PubMed ID: 22244008
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases.
    Berger M; Pinciaro PJ;
    J Clin Immunol; 2004 Jul; 24(4):389-96. PubMed ID: 15163895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.